Modeling dopamine system dysfunction in experimental animals.
Quite a substantial number of human disorders have been associated with a primary or a secondary impairment of one or several of the dopaminergic pathways. Among disorders associated with a primary impairment of dopaminergic transmission are Parkinson's disease, striatonigral degeneration, progressive supranuclear palsy, and possibly schizophrenia. Diseases of secondary dopamine dysfunction are chiefly represented by Huntington's disease in which dopaminergic transmission is being interrupted by progressive loss of the striatal neurons bearing the postsynaptic D1- and D2-dopamine receptors. Central dopaminergic systems have anatomical as well as organizational properties that render them unique by comparison to other neurotransmission systems, making them able to play a pivotal role in the modulation of various important brain functions such as locomotor activity, attention, and some cognitive abilities. These properties of dopamine neurons have obviously several implications in the clinical expression of human disorders involving dopamine neuron dysfunction. In addition, they can greatly influence the clinical/behavioral consequences of experimental lesions in animal models of dopamine dysfunctions.
Hantraye
P
P
Service Hospitalier Frederic Joliot, Orsay, France. hantraye@uriens.shfj.cea.fr
D000818:Animals; D001921:Brain / Q000000981:diagnostic imaging / Q000503:physiopathology*; D001927:Brain Diseases / Q000000981:diagnostic imaging / Q000503:physiopathology*; D002250:Carbon Radioisotopes; D004195:Disease Models, Animal; D004298:Dopamine / Q000502:physiology*; D006801:Humans; D009474:Neurons / Q000502:physiology*; D019275:Radiopharmaceuticals; D011954:Receptors, Dopamine / Q000502:physiology; D009435:Synaptic Transmission; D014055:Tomography, Emission-Computed
D002250:Carbon Radioisotopes; D019275:Radiopharmaceuticals; D011954:Receptors, Dopamine; D004298:Dopamine